Real-World Evidence to Reinforce Clinical Trial Evidence in Health Technology Assessment: A Critical Review of Real-World Evidence Requirements from Seven Countries and Recommendations to Improve Acceptance
Background: Real-world evidence (RWE) can reinforce clinical trial evidence in health technology assessment (HTA). Objectives: Review HTA bodies’ (HTAbs) requirements for RWE, real uses, and acceptance across seven countries (Brazil, Canada, France, Germany, Italy, Spain, and the United Kingdom) and...
שמור ב:
| Principais autores: | , , , , , , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
MDPI AG
2024-05-01
|
| סדרה: | Journal of Market Access & Health Policy |
| נושאים: | |
| גישה מקוונת: | https://www.mdpi.com/2001-6689/12/2/9 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
